New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Benitec Biopharma Inc.
BNTC
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

205M

Biotechnology

Next Earning date - 11 Nov 2024

205M

Biotechnology

Next Earning date - 11 Nov 2024

11.48USD
Shape0.26 ( 2.32%)
favorite-chart

Relative Strenght

97
favorite-chart

Volume Buzz

120%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated October 21, 2024
1W 17.02 % 1M 29.28 % 3M 28.12 % 1Y 256.52 %

Key Metrics

Shape
  • Market Cap

    205.42M


  • Shares Outstanding

    17.89M


  • Share in Float

    14.93M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    11.48


  • Average Volume

    27159


  • Beta

    0.9


  • Range

    2.69-12.89


  • Industry

    Biotechnology


  • Website

    https://benitec.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

34236.80x

P/S Ratio

0.99x

P/B Ratio

0.0

Debt/Equity

-362516.7%

Net Margin

$-5.5

EPS

How BNTC compares to sector?

P/E Ratio

Relative Strength

Shape

BNTC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1M

ShapeNaN%

2025-Revenue

$8.05

Shape-594%

2025-EPS

$1M

Shape79%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Oppenheimer

initialise

Previous: Not converted

2024-10-15

Now: Outperform

Guggenheim

initialise

Previous: Not converted

2024-09-12

Now: Buy

Piper Sandler

initialise

Previous: Not converted

2024-06-13

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-7.99
vs -10.54

Q4.22

arrow
arrow

N/A

-3.40
vs -10.03

Q1.23

arrow
arrow

N/A

-2.72
vs -6.80

Q2.23

arrow
arrow

N/A

-2.83
vs -10.54

Q3.23

arrow
arrow

N/A

-2.76
vs -7.99

Q4.23

arrow
arrow

N/A

-2.64
vs -3.40

Q1.24

arrow
arrow

N/A

-1.64
vs -2.72

Q2.24

arrow
arrow

N/A

-1.32
vs -2.83

Q3.24

arrow
arrow

N/A

-0.79
vs -2.76

Q4.24

arrow
arrow

N/A

-0.65
vs -2.64

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

+4700%

48K  vs 1K

Q2.22

arrow
arrow

-100%

NA  vs 2K

Q3.22

arrow
arrow

NA

472K  vs NA

Q4.22

arrow
arrow

-44%

14K  vs 25K

Q1.23

arrow
arrow

+13%

54K  vs 48K

Q2.23

arrow
arrow

NA

7K  vs NA

Q3.23

arrow
arrow

-100%

NA  vs 472K

Q4.23

arrow
arrow

-100%

NA  vs 14K

Q1.24

arrow
arrow

-89%

6K  vs 54K

Q2.24

arrow
arrow

-100%

NA  vs 7K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-38%

-0.38
vs -1.76

Q4.22

arrow
arrow

-58%

-0.58
vs -0.38

Q1.23

arrow
arrow

-95%

-0.95
vs -0.58

Q2.23

arrow
arrow

-2307%

-23.07
vs -0.95

Q3.23

arrow
arrow

-27%

-0.27
vs -23.07

Q4.23

arrow
arrow

-44%

-0.44
vs -0.27

Q1.24

arrow
arrow

-37%

-0.37
vs -0.44

Q2.24

arrow
arrow

-10%

-0.10
vs -0.37

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

15

15
vs 13

15%

Q2.22

arrow
arrow

19

19
vs 15

27%

Q3.22

arrow
arrow

20

20
vs 19

5%

Q4.22

arrow
arrow

23

23
vs 20

15%

Q1.23

arrow
arrow

20

20
vs 23

-13%

Q2.23

arrow
arrow

16

16
vs 20

-20%

Q3.23

arrow
arrow

1

1
vs 16

-94%

Q2.24

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News